ArticleAnnals of medicine2026
Magnetic resonance imaging changes of thigh muscles in dermatomyositis patients with anti-Mi2 antibody.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnti-complex nucleosomal remodelling histone deacetylase (Mi2)-positive dermatomyositis (DM) is characterized by severe muscle damage. This study investigated muscle magnetic resonance imaging (MRI) features in anti-Mi2-positive DM, compared them with other DM subtypes, and evaluated their associations with clinical features.
methodsDM patients who underwent thigh MRI were enrolled, including 20 anti-Mi2-positive, 20 anti-TIF1γ-positive, 15 anti-NXP2-positive, and 19 anti-MDA5-positive cases. Clinical and imaging data were collected and compared across subtypes. The relationship between MRI features and clinical characteristics was analysed in the anti-Mi2-positive subgroup.
resultsAmong the four subtypes, anti-Mi2-positive DM had the highest myofascial oedema frequency in the sartorius and the lowest in the biceps femoris (both
conclusionThis study delineated baseline thigh MRI patterns in anti-Mi2-positive DM and demonstrated that baseline muscle oedema severity correlated with serological and clinical indicators of muscle damage. Additionally, findings from a small longitudinal cohort suggested a potential role for thigh MRI in assessing and monitoring muscle disease activity in this subtype, although these results are preliminary and require validation in larger studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.